SARS-CoV-2 & Cardiac Amyloidosis

Pioneering research on the relationship between SARS-CoV-2 infection and cardiac amyloidosis. Our work investigates how SARS-CoV-2 surface and secretory proteins interact with amyloidogenic proteins responsible for cardiac amyloidosis, highlighting protein interactions and their clinical implications for cardiovascular health in collaboration with international partners.

Current Investigations

Our laboratory heavily focuses on understanding the molecular underpinnings described above. Through a combination of in-silico predictions and in-vitro experimental validation, we aim to bridge the gap between basic mechanistic understanding and translational therapeutic strategies.